Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymalin

Thymulin, Thymic Factor, Serum Thymic Factor, Facteur Thymique Serique

Quick Stats
Studies 202
Trials 37
Score 2
2008 pubmed

[Effects of mercazolyl and L-thyroxine on the antiedematous activity of immunotropic preparations during development of toxic brain edema and swelling].

Platonov. I A IA; Anashchenkova. T A TA; Andreeva. T A TA

Key Findings

  • Thyroid hypo‑ or hyper‑function alters development of toxic brain edema in rats
  • L‑thyroxine alone increased brain water content, worsening edema
  • Combining mercazolyl, L‑thyroxine, and thymalin (plus other immune peptides) reduced brain tissue density versus controls

Practical Outcomes

  • The results hint that thymalin might help counter brain swelling when thyroid hormones are out of balance, but the study is in rats and uses high drug doses. Biohackers should view this as a mechanistic clue rather than a ready‑to‑use supplement regimen, and await human trials before trying it for edema or brain health.

Summary

In rats, messing with thyroid hormones changes how brain swelling happens, and giving a mix of drugs—including the peptide thymalin—seemed to lower brain tissue density (a sign of less swelling) compared to untreated animals. However, this is early animal work, not a proven human protocol.

Abstract

Dysfunction of thyroid gland plays an important role in the pathogenesis of brain edema and swelling. Toxic brain edema and swelling was modeled under condition of hypo- and hyperfunction of thyroid gland. Mercazolyl and L-thyroxine ambiguously influence the development of toxic brain edema and swelling in rats. L-thyroxin (35.7 microg/kg) favors increase in the water content in brain tissue, which can be considered as synergism with the edematous factor and the formation of brain tissue susceptibility to the development of brain edema and swelling. The administration of mercazolyl (5 mg/kg) and L-thyroxin (35.7 microg/kg) with thymogen (10 microg/kg), thymalin (1.2 mg/kg), cycloferon (0.5 mg/kg) results in decreasing brain tissue density as compared to intact animals. Dysfunction of the thyroid gland leads to changes in pharmacodynamics of immune preparations, which results in a decrease of their antiedematous activity.

Study Information

Provider

pubmed

Year

2008